Pathological functions and therapeutic targets of post-translational modifications in pan-cancer
-
-
REFERENCES
[1] Geffen, Y., Anand, S., Akiyama, Y., et al. (2023). Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell 186: 3945−3967. DOI: 10.1016/j.cell.2023.07.013. [2] Wang, H., Yang, L., Liu, M., and Luo, J. (2023). Protein post-translational modifications in the regulation of cancer hallmarks. Cancer Gene. Ther. 30: 529−547. DOI: 10.1038/s41417-022-00464-3. [3] Harada, K., Carr, S.M., Shrestha, A., and La Thangue, N.B. (2023). Citrullination and the protein code: Crosstalk between post-translational modifications in cancer. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 378: 20220243. DOI: 10.1098/rstb.2022.0243. [4] Yang, Y.H., Wen, R., Yang, N., et al. (2023). Roles of protein post-translational modifications in glucose and lipid metabolism: Mechanisms and perspectives. Mol. Med. 29: 93. DOI: 10.1186/s10020-023-00684-9. -
ABOUT THIS ARTICLE
Cite this article:
Zhu Y., Xu R., Wang L., et al., (2023). Pathological functions and therapeutic targets of post-translational modifications in pan-cancer. The Innovation Medicine 1(3), 100045. https://doi.org/10.59717/j.xinn-med.2023.100045
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Zhu Y., Xu R., Wang L., et al., (2023). Pathological functions and therapeutic targets of post-translational modifications in pan-cancer. The Innovation Medicine 1(3), 100045. https://doi.org/10.59717/j.xinn-med.2023.100045
Format
Content
DownLoad:
-
Figure 1.
The shared pattern of post-translational modifications (PTMs) changes observed across over 1,000 patients spanning 11 diverse cancer types highlights the prominent role that PTMs play in these characteristic cancer processes
